Results 101 to 110 of about 147 (117)

Botulinum Toxin Type A in the Treatment of Raynaud's Phenomenon

Journal of Hand Surgery, 2010
Michael W Neumeister
exaly  

ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon

Vasa - European Journal of Vascular Medicine, 2017
Daniel Staub, Jill Belch, Dan-Mircea Olinic   +2 more
exaly  

Botulinum Toxin A Treatment of Raynaud's Phenomenon: A Review

Seminars in Arthritis and Rheumatism, 2012
James Higgins, Matthew Iorio
exaly  

Treatment of Raynaud's phenomenon

Autoimmunity Reviews, 2008
Ricard Cervera, Roger Abramino Levy, Mario García-Carrasco   +2 more
exaly  

Raynaud's phenomenon

Best Practice and Research in Clinical Rheumatology, 2020
Fredrick M Wigley, Ariane Herrick
exaly  

Functional vascular diseases: Raynaud’s syndrome, acrocyanosis and erythromelalgia

Vasa - European Journal of Vascular Medicine, 2010
H Heidrich
exaly  

Raynaud's phenomenon

Lancet, The, 2001
Joel Block, Winston Sequeira
exaly  

International consensus criteria for the diagnosis of Raynaud's phenomenon

Journal of Autoimmunity, 2014
, M Eric Gershwin, Roger Hesselstrand
exaly  

Blockade of Vasospastic Attacks by α2-Adrenergic but Not α1-Adrenergic Antagonists in Idiopathic Raynaud’s Disease

Circulation, 1995
, R R Freedman, Robert R Freedman
exaly  

RAYNAUD'S PHENOMENON IN RHEUMATOID ARTHRITIS

Rheumatology, 1994
C Cervini, W Grassi
exaly